Há pessoas que, mesmo depois de "negativadas" após se infectar com o coronavírus, continuam tendo um ou mais sintomas da doença.O que a ciência tem a dizer sobre a pós-COVID ou COVID longa? Por que isso importa?Confira a parte 1 deste episódio duplo, no papo entre o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza.> OUÇA (52min 08s)*Naruhodo! é o podcast pra quem tem fome de aprender. Ciência, senso comum, curiosidades, desafios e muito mais. Com o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza.Edição: Reginaldo Cursino.http://naruhodo.b9.com.br*PARCERIA: ALURAAprofunde-se de vez: garantimos conhecimento com profundidade e diversidade, para se tornar um profissional em T - incluindo programação, front-end, data science, devops, ux & design, mobile, inovação & gestão.Navegue sua carreira: são mais de 1300 cursos e novos lançamentos toda semana, além de atualizações e melhorias constantes.Conteúdo imersivo: faça parte de uma comunidade de apaixonados por tudo que é digital. Mergulhe na comunidade Alura.Aproveite o desconto para ouvintes Naruhodo no link:https://bit.ly/naruhodo_alura*REFERÊNCIASDiário de um Extubado - Episódioshttps://podcasts.apple.com/us/podcast/diário-de-um-extubado/id1528224825A multinational Delphi consensus to end the COVID-19 public health threathttps://www.nature.com/articles/s41586-022-05398-2Acute and postacute sequelae associated with SARS-CoV-2 reinfectionhttps://www.nature.com/articles/s41591-022-02051-3#MOESM1Long COVID or Post-COVID Conditionshttps://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.htmlVaccine hesitancy in the era of COVID-19https://www.sciencedirect.com/science/article/pii/S0033350621000834?casa_token=yFG73GWZPtcAAAAA:zbTt9INuQaw9TEDv7gmYkruwwXhIjCLoW8BAO0ZhwUjV5WaC9sRiT7SjTdSKxNsTT3_pf6oPF7AGlobal Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysishttps://www.mdpi.com/2076-393X/10/8/1356Partisanship and the Politics of COVID Vaccine Hesitancyhttps://www.journals.uchicago.edu/doi/abs/10.1086/719918Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?https://www.tandfonline.com/doi/full/10.1080/21645515.2021.1893062How and why patients made Long Covidhttps://www.sciencedirect.com/science/article/pii/S0277953620306456Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of carehttps://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00385-4/fulltextMore than 50 long-term effects of COVID-19: a systematic review and meta-analysishttps://www.nature.com/articles/s41598-021-95565-8One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptomshttps://www.mdpi.com/2077-0383/10/15/3305Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infectionshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021204/Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046154/Mast cell activation symptoms are prevalent in Long-COVIDhttps://www.sciencedirect.com/science/article/pii/S1201971221007517Antihistamines for Postacute Sequelae of SARS-CoV-2 Infectionhttps://www.sciencedirect.com/science/article/pii/S155541552100547XChronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccinehttps://www.sciencedirect.com/science/article/pii/S0264410X15014334Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled studyhttps://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-11-37Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?https://www.frontiersin.org/articles/10.3389/fmed.2020.606824/fullChronic fatigue syndrome and long covid: moving beyond the controversyhttps://www